Balazs Odler
@odlerb
Followers
388
Following
2K
Statuses
370
MD PhD | Nephrologist with interest in kidney autoimmunity at the @MedUniGraz | ERA YNP Board Member | views my own 🇪🇺
Graz, Österreich
Joined December 2018
Just published in @Kidney_Int - The impact of PLEX and GC on early kidney function changes in AAV. ( This analysis provides another important piece of the “PLEX puzzle”. Many thanks to my co-authors, the PIs and especially to @AKronbichler and David Jayne.
4
5
29
RT @Kidney_Int: The effects of #plasmaexchange and #glucocorticoids on early kidney function among patients with #ANCA-associated #vasculit…
0
36
0
RT @Lupusreference: ✅ Let's see who will bring forward the best arguments 😏😇 #Lupus nephritis - standard of care (for all, will already be…
0
12
0
RT @Kidney_Int: Lupus nephritis: redefining the treatment goals #KIEditorial #OpenAccess #lupusnephritis
@MayoC…
0
78
0
RT @anzvasc: Website's up! All things #vasculitis in Melbourne Feb 2026. Key dates, things to do and promotional t…
0
11
0
RT @ynptweets: 👀 Check our new snapshot summary on fluid removal targets during intermittent renal replacement therapy for AKI! https://t…
0
16
0
RT @ynptweets: 🔥 Our snapshot summary on a survey study on what patients with CKD actually want to know! Jet Mild…
0
17
0
It was my pleasure and a great experience to discuss the role of plasma exchange in #AAV at the @OhioStateNeph. Brilliant fellows and a surprise visit by @LynnFussner. Thank you @SalemAlmaani, @BradRovin and Jessica Greco for the wonderful hosting!
1
1
15
The @ynptweets board meeting in Parma, Italy was a fantastic brainstorming about current and exciting future projects. @fcaravacafontan and Michele Eisenga were online with us! Stay tuned about our activities via @ERAkidney website:
Our board had a meeting at @ERAkidney headquarters in Parma! Two days of great discussions on our current and future activities!
0
1
15
RT @hjanders_hans: Now open access in @NDTsocial Obinutuzumab versus RTX for refractory primary membranous nephropathy 🧐This retrospec…
0
39
0
Congratulations to @GaucklerP and @AKronbichler for leading this important study of rituximab in podocytopathies. It was a real multi-centre effort with important results for clinical practice. See this very useful thread below 👇🏻
Just published in @JASN_News - our long-term outcome analysis of rituximab in podocytopathies: A special thank you to my partner in crime @GaucklerP and my fantastic past @ERAkidney fellow Anna Matyjek. This has been work over the past 6 years!
0
1
8
We had a very successful #EUVAS symposium in Graz discussing exciting topics on systemic vasculitides. Many thanks to all the wonderful speakers, fellows, and participants for being a part of it, and to @MedUniGraz for giving us the opportunity to host this event!
0
2
27
Our journey in Brazil comes to an end. Starting with an amazing @MayoClinicNeph meeting in Rio and ending with a wonderful evening in Recife. The beauty and hospitality of this country have left me deeply impressed. 🇧🇷 A special thanks to Izabel and @gvajgel for having us!
0
1
16
Thank you for having us @gvajgel and @marclebiodoura1 . Brasil is just amazing!
Two amazing talks: @AKronbichler - "B-cell depletion in MCD e FSGS" and @odlerb - "Preventing infections in immunocompromised patients with glomerular diseases". Many thanks! Grateful to @gvajgel for arranging this meeting in Recife
0
0
8
RT @hjanders_hans: Now online at @NDTsocial @HerrmannMd Immune checkpoint inhibitor-associated nephritis - treatment standard 🧐A subset…
0
55
0
@IoannisParodis is one of the most inspiring physician scientists I know. Go for this opportunity if you are interested in lupus research!
Interested in #Autoimmunity and #Rheumatology? Excited about #Lupus research? We’re looking for a post-doc to join our team at the @karolinskainst! #PostDocOpportunity #Research #JoinUs
0
0
3
RT @HoromanskiMd: Our most recent publication on pregnancy outcomes in systemic vasculitis - crucial for clinicians to be aware of these in…
0
10
0